Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance
Claire Martin, Carleen Cullinane, Laura Kirby, Shatha AbuHammad, Emily J. Lelliott, Kelly Waldeck, Richard J. Young, Natalie Brajanovski, Donald P. Cameron, Rachael Walker, Elaine Sanij, Gretchen Poortinga, Ross D. Hannan, Richard B. Pearson, Rodney J. Hicks, Grant A. McArthur, Karen E. Sheppard (2017). Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance. , 142(10), DOI: https://doi.org/10.1002/ijc.31220.
Article149 days agoAmino acid-dependent signaling <i>via</i> S6K1 and MYC is essential for regulation of rDNA transcription
Jian Kang, Eric Kusnadi, A. J. Ogden, Rodney J. Hicks, Lukas Bammert, Ulrike Kutay, Sandy Hung, Elaine Sanij, Ross D. Hannan, Katherine M. Hannan, Richard B. Pearson (2016). Amino acid-dependent signaling <i>via</i> S6K1 and MYC is essential for regulation of rDNA transcription. , 7(31), DOI: https://doi.org/10.18632/oncotarget.10346.
Article149 days agoImaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis
Anna Galligan, Amir Iravani, Arian Lasocki, Roslyn Wallace, Alison M. Weppler, Nirupa Sachithanandan, Cherie Chiang, Peter G. Colman, John M. Wentworth, Lavinia Spain, George Au‐Yeung, Belinda Lee, Thomas W. H. Kay, Rodney J. Hicks, Shahneen Sandhu, Balasubramanian Krishnamurthy (2023). Imaging for assessment of cancer treatment response to immune checkpoint inhibitors can be complementary in identifying hypophysitis. , 14, DOI: https://doi.org/10.3389/fendo.2023.1295865.
Article149 days agoLuPARP: Phase 1 trial of 177Lu-PSMA-617 and olaparib in patients with metastatic castration resistant prostate cancer (mCRPC).
Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Megan Crumbaker, Mathias Bressel, Rhonda Huynh, Patricia Banks, Roslyn Wallace, Anis Hamid, Andrisha Jade Inderjeeth, Ben Tran, Arun Azad, Ramin Alipour, Grace Kong, Aravind Ravi Kumar, Javad Saghebi, Scott Williams, Timothy Akhurst, Rodney J. Hicks, Michael S. Hofman (2023). LuPARP: Phase 1 trial of 177Lu-PSMA-617 and olaparib in patients with metastatic castration resistant prostate cancer (mCRPC).. , 41(16_suppl), DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.5005.
Article149 days agoIncreased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis
Anna Galligan, Roslyn Wallace, Balasubramanian Krishnamurthy, Thomas W. H. Kay, Nirupa Sachithanandan, Cherie Chiang, Shahneen Sandhu, Rodney J. Hicks, Amir Iravani (2023). Increased Thyroidal Activity on Routine FDG-PET/CT after Combination Immune Checkpoint Inhibition: Temporal Associations with Clinical and Biochemical Thyroiditis. , 15(24), DOI: https://doi.org/10.3390/cancers15245803.
Article149 days ago